Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-08-12 | New | $210,000 | Unknown | Debt Only | SEC link | |
| 2025-02-11 | New | $250,000 | $250,000 | Debt Only | 06b | SEC link |
| 2024-07-12 | New | $125,000 | $125,000 | Debt Only | 06b | SEC link |
| 2023-08-11 | New | $250,000 | $250,000 | Debt Only | 06b | SEC link |
| 2023-03-09 | New | $300,000 | $300,000 | Other | 06b | SEC link |
| 2022-03-16 | New | $300,000 | $300,000 | Other | 06b | SEC link |
| 2016-09-30 | New | Yet to Sell | $0 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| L. Edward Cannon | Director, Executive |
| Lovick Edward Cannon | Director, Executive |
| Thomas Chris Cannon | Director |
| Max D. Cooper | Director |
| Greg Dane | Director |
| Gregory Dane | Director |